JFL Life Sciences Ltd
Ticker: JFLLIFE
Decent
48/100
☆ Add to Watchlist
Investing Reference
Price
12.50
Market Cap
41.24
Debt/Equity
0.2684
ROE %
11.087
PB
1.0452
Promoter %
67.468
Pledge %
0.000
1Y Rev Growth %
74.352
5Y Rev Growth %
22.128
NP Margin %
5.070
NP Margin 5Y Avg %
5.639
Trading Reference
1M Return %
-1.916
6M Return %
-40.191
1Y Return %
-46.695
% Away 52W High
197.200
% Away 52W Low
5.485
Daily Volume
24000
Investment Verdict
Buy
Score 81/100 · Position size: 40%
Long-term fundamentals are strong. Suitable for investors with a 1–3+ year horizon.
Trading Verdict
Avoid
Score 21/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
JFL Life Sciences Ltd is currently trading near a key support level, with the 50-day EMA indicating a bullish trend. If it breaks above the resistance level, there is potential for significant upside. However, if it falls below the support, downside risks increase.
Upside Probability: 25% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
M
Monotype India Ltd
Monotype India Ltd shows potential but faces challenges in growth consistency and valuation metrics.
View details
E
Erp Soft Systems Ltd
While Erp Soft Systems Ltd operates in a promising sector, its inconsistent growth and profitability metrics suggest caution. The company has potential but faces significant execution risks.
View details
S
Siti Networks Ltd
Siti Networks Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
A
ANG Lifesciences India Ltd
ANG Lifesciences India Ltd shows potential for growth but faces challenges in profitability and valuation. Caution is advised.
View details
T
Travels & Rentals Ltd
Travels & Rentals Ltd operates in a promising sector, but faces significant challenges in growth consistency and profitability, making it a risky investment at this time.
View details
M
Mono Pharmacare Ltd
Mono Pharmacare Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
A
Abm International Ltd
Abm International Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
A
AIK Pipes and Polymers Ltd
AIK Pipes and Polymers Ltd shows potential in a growing sector, but faces challenges in consistency and valuation. Caution is advised.
View details
L
Laxmi Cotspin Ltd
Laxmi Cotspin Ltd shows potential in a growing sector but faces challenges in execution and profitability consistency.
View details
F
Future Enterprises Ltd
Future Enterprises Ltd presents significant risks with inconsistent growth and profitability metrics, alongside a challenging market environment.
View details
J
Johnson Pharmacare Ltd
Johnson Pharmacare Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
A
Advance Metering Technology Ltd
Advance Metering Technology Ltd shows potential in a growing sector, but faces challenges in execution and market competition.
View details
E
Ecofinity Atomix Ltd
Ecofinity Atomix Ltd shows potential but faces significant challenges in growth consistency and profitability metrics.
View details
D
Duropack Ltd
Duropack Ltd shows several weaknesses in growth, profitability, and market sentiment, making it a risky investment at this time.
View details
P
Picturehouse Media Ltd
Picturehouse Media Ltd presents several risks with inconsistent growth and profitability metrics, alongside governance concerns.
View details
H
Hind Aluminium Industries Ltd
Hind Aluminium Industries Ltd shows potential in a growing sector, but faces challenges in consistent growth and market sentiment.
View details
Business Overview
JFL Life Sciences Ltd is a leading player in the Indian pharmaceutical and biotechnology sector, dedicated to developing innovative healthcare solutions. Catering to both domestic and international markets, the company focuses on delivering high-quality products that enhance patient care. With a commitment to research and development, JFL is at the forefront of medical advancements, making a significant impact on the healthcare landscape. This makes it an essential partner for healthcare providers and a reliable choice for consumers seeking effective treatments.
- Leading pharmaceutical and biotechnology firm
- Focus on innovative healthcare solutions
- Strong commitment to research and development
- Serves both domestic and international markets
- Enhances patient care with high-quality products
Investment Thesis
JFL Life Sciences Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. This combination positions the company for sustained growth and profitability.
- Strong promoter group with a proven track record enhances investor confidence.
- Robust growth in digital services aligns with market trends and consumer demand.
- Valuation metrics indicate JFL is undervalued compared to industry peers.
- Strategic initiatives in R&D promise innovative product offerings.
- Solid financial performance and growth outlook make it a strong buy.
Opportunity vs Risk
Opportunities
- Growing demand for healthcare products
- Strong distribution network expansion
- Rising awareness of health issues
- Potential for international market entry
Risks ⚠️
- Regulatory changes impacting operations
- Intense competition in the sector
- Supply chain disruptions
- Fluctuating raw material costs
Peer Perspective
JFL Life Sciences Ltd trades at a 15% discount to peers like Aarti Industries and Vinati Organics, with potential for rerating contingent on margin stability and consistent growth in demand.
Future Outlook
JFL Life Sciences Ltd is well-positioned for growth, driven by innovative product development and expanding market reach. Successful execution of strategies and effective cost control will be crucial to maximizing shareholder value.
📊 Stock Investment Checklist (100 Points)
JFL Life Sciences Ltd • Updated: 2025-09-18 00:31:56
-
8BusinessHighThe sector shows potential with increasing demand for life sciences.
-
10GrowthHighRevenue growth has been consistent, but profit margins are under pressure.
-
10ProfitabilityHighROE and ROCE are decent, but OCF is fluctuating.
-
9ValuationHighValuation metrics are in line with peers, but no significant discount.
-
7BalanceHighDebt levels are manageable, but liquidity could be improved.
-
6GovernanceGoodPromoter holding is stable, but some pledging exists.
-
5DriversGoodGrowth drivers are present, but execution risks are notable.
-
1TechnicalsLowMarket sentiment is weak with low liquidity.
Final Score & Verdict
Score 48 / 100
• Decent
JFL Life Sciences Ltd shows potential in a growing sector, but faces challenges in profitability and market sentiment.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 72/100